Abstract:The downregulation of SIRT1 in the SDH, following CCI, leads to increased histone H3 acetylation in the Scn3a promoter region. This promotes the expression of Nav1.3, which subsequently causes CaMKIIα+ neurons activation, resulting in pain. Alleviating pain by reversing SIRT1 downregulation can be a potential therapeutic target for local spinal cord analgesics. Aims Neuropathic pain is a common chronic pain disorder, which is largely attributed to spinal central sensitization. Calcium/calmodulin‐dependent protein kinase II alpha (CaMKIIα) activation in the spinal dorsal horn (SDH) is a major contributor to spinal sensitization. However, the exact way that CaMKIIα‐positive (CaMKIIα+) neurons in the SDH induce neuropathic pain is still unclear. This study aimed to explore the role of spinal CaMKIIα+ neurons in neuropathic pain caused by chronic constriction injury (CCI) and investigate the potential epigenetic mechanisms involved in CaMKIIα+ neuron activation. Methods CCI‐induced neuropathic pain mice model, Sirt1loxP/loxP mice, and chemogenetic virus were used to investigate whether the activation of spinal CaMKIIα+ neurons is involved in neuropathic pain and its involved mechanism. Transcriptome sequence, western blotting, qRT‐PCR, and immunofluorescence analysis were performed to assay the expression of related molecules and activation of neurons. Co‐immunoprecipitation was used to observe the binding relationship of protein. Chromatin immunoprecipitation (ChIP)‐PCR was applied to analyze the acetylation of histone H3 in the Scn3a promoter region. Results The expression of sodium channel Nav1.3 was increased and the expression of SIRT1 was decreased in the spinal CaMKIIα+ neurons of CCI mice. CaMKIIα neurons became overactive after CCI, and inhibiting their activation relieved CCI‐induced pain. Overexpression of SIRT1 reversed the increase of Nav1.3 and alleviated pain, while knockdown of SIRT1 or overexpression of Nav1.3 promoted CaMKIIα+ neuron activation and induced pain. By knocking down spinal SIRT1, the acetylation of histone H3 in the Scn3a (encoding Nav1.3) promoter region was increased, leading to an increased expression of Nav1.3. Conclusion The findings suggest that an aberrant reduction of spinal SIRT1 after nerve injury epigenetically increases Nav1.3, subsequently activating CaMKIIα+ neurons and causing neuropathic pain.

SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting Mglur1/5

Intrathecal Administration of SRT1720 Relieves Bone Cancer Pain by Inhibiting the CREB/CRTC1 Signalling Pathway

Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a

Role of Spinal Neuronal CREB-regulated Transcription Coactivator 1 in Maintenance of Bone Cancer Pain in Mice

Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

miR-155-5p in the spinal cord regulates hypersensitivity in a rat model of bone cancer pain

MiR-135-5p Alleviates Bone Cancer Pain by Regulating Astrocyte-Mediated Neuroinflammation in Spinal Cord through JAK2/STAT3 Signaling Pathway

Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model

Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models

Brain‐derived Neurotrophic Factor Modulates N‐methyl‐D‐aspartate Receptor Activation in a Rat Model of Cancer‐induced Bone Pain

PGC‐1α activation ameliorates cancer-induced bone pain via inhibiting apoptosis of GABAergic interneurons

Inhibition of Glial Activation in Rostral Ventromedial Medulla Attenuates Mechanical Allodynia in a Rat Model of Cancer-Induced Bone Pain

Activation of the BMP2-SMAD1-CGRP Pathway in Dorsal Root Ganglia Contributes to Bone Cancer Pain in a Rat Model

Role of Spinal Neuronal Mas-related Gene Receptor C in Maintenance of Bone Cancer Pain in Mice

Downregulated CAV-1 in Mouse Spinal Cord May Alleviate Bone Cancer Pain by Inhibiting the ERK/CREB Pathway.

CREB-regulated Transcription Coactivator 1 Enhances CREB-dependent Gene Expression in Spinal Cord to Maintain the Bone Cancer Pain in Mice.

Mas-Related Gene (mrg) C Activation Attenuates Bone Cancer Pain Via Modulating Gi and NR2B

Reduction of SIRT1 Epigenetically Upregulates NALP1 Expression and Contributes to Neuropathic Pain Induced by Chemotherapeutic Drug Bortezomib

Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice

Activation of Spinal Mrgc-Gi-Nr2b-Nnos Signaling Pathway by Mas Oncogene-Related Gene C Receptor Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

SIRT1 mediates the excitability of spinal CaMKIIα‐positive neurons and participates in neuropathic pain by controlling Nav1.3